Neogen (NASDAQ:NEOG) Stock Rating Upgraded by Zacks Research

Neogen (NASDAQ:NEOG) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Zacks Research also issued estimates for Neogen’s Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at $0.08 EPS, Q3 2026 earnings at $0.08 EPS, Q4 2026 earnings at $0.08 EPS, FY2026 earnings at $0.30 EPS, Q1 2027 earnings at $0.08 EPS, Q2 2027 earnings at $0.09 EPS, Q4 2027 earnings at $0.09 EPS, FY2027 earnings at $0.36 EPS and FY2028 earnings at $0.35 EPS.

A number of other research analysts have also commented on the company. Piper Sandler lowered their price target on Neogen from $6.40 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, April 22nd. William Blair downgraded Neogen from an “outperform” rating to a “market perform” rating in a research report on Tuesday, July 29th. Finally, Guggenheim decreased their price target on Neogen from $13.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, June 30th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $7.50.

Neogen Stock Up 0.5%

NEOG opened at $5.60 on Wednesday. The stock’s 50 day moving average price is $5.11 and its 200 day moving average price is $6.67. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.32 and a quick ratio of 2.22. The stock has a market cap of $1.22 billion, a P/E ratio of -1.11 and a beta of 1.79. Neogen has a 12 month low of $3.87 and a 12 month high of $17.95.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in shares of Neogen by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 23,550,128 shares of the company’s stock valued at $204,180,000 after acquiring an additional 1,912,877 shares during the last quarter. Clarkston Capital Partners LLC raised its position in shares of Neogen by 123.2% during the second quarter. Clarkston Capital Partners LLC now owns 14,005,725 shares of the company’s stock worth $66,947,000 after purchasing an additional 7,729,650 shares during the period. Gates Capital Management Inc. purchased a new stake in shares of Neogen during the first quarter valued at $79,391,000. Norges Bank purchased a new stake in shares of Neogen during the second quarter valued at $43,387,000. Finally, Conestoga Capital Advisors LLC boosted its position in shares of Neogen by 0.4% in the 1st quarter. Conestoga Capital Advisors LLC now owns 8,540,859 shares of the company’s stock valued at $74,049,000 after purchasing an additional 37,271 shares during the period. Institutional investors and hedge funds own 96.73% of the company’s stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.